Subscribe to RSS
DOI: 10.1055/s-0043-1762913
Introduction to Diagnostic Challenges in Movement Disorders
![](https://www.thieme-connect.de/media/sin/202301/lookinside/thumbnails/10-1055-s-0043-1762913_v43n1preface-1.jpg)
![](https://www.thieme-connect.de/media/sin/202301/thumbnails/10-1055-s-0043-1762913-iv43n1preface-1.jpg)
![Zoom Image](/products/assets/desktop/css/img/icon-figure-zoom.png)
![](https://www.thieme-connect.de/media/sin/202301/thumbnails/10-1055-s-0043-1762913-iv43n1preface-2.jpg)
![Zoom Image](/products/assets/desktop/css/img/icon-figure-zoom.png)
In recent history, the demise of the clinical neurologist was first predicted in the early 1970s with the advent of the computed tomography scan.[1] Answers to localization and presence of structural abnormalities including ischemic stroke and hemorrhage could be answered by direct visualization of the brain, thereby rendering the clinician's input ancillary, at best. Instead, clinicians incorporated available modalities into their repertoire and enabled major treatment advances. A stellar example would be in stroke care, where such an approach led to eventual use of thrombolysis to minimize disability in the mid-90s and eventually, incorporation of endovascular treatments to reverse deficit in the last few years.[2]
The clinical diagnostician is as pertinent in the field of movement disorders as any, where clinical diagnosis is regarded as the gold standard to appropriate clinical care.[3] [4] With an aging population and projected increase in neurological disorders, and fewer than 5 neurologists per 100,000 people in the United States and even fewer elsewhere,[5] [6] [7] [8] it is critical that diagnostic skills be correctly taught, discussed, and shared to provide care to patients perhaps seeing us in clinic on the worst day of their lives. It is therefore important that our skills in diagnosis not only be celebrated and passed on from one generation to the next, but also constantly revisited and perfected. The field of movement disorders, like others in medicine, is ripe with silos, gaps, and overlap between disorders. Accurate diagnosis, when delivered the correct way, can be therapeutic in its own right. It can lead to symptomatic treatment, prognostication, and better informed counseling. Clinical diagnosis in movement disorders can inform the development of validated scales and personalized symptomatic therapies. In addition, recent developments in imaging methods, neurophysiology, and genetics offer the chance for the clinician to incorporate the latest advances in biomedical research.
Throughout this issue, we bring together a wonderful collection of movement disorder experts to discuss diagnostic challenges in various movement disorders. We present diagnostic approaches to movement disorders, including but not limited to ataxia, chorea, tremor, and functional neurological disorders. We discuss the use of investigational modalities such as neuroimaging in parkinsonism. We further discuss current gaps, approaches to address them in the clinic, and attempt to foresee what the near future might bring. We highlight contemporary clinical issues such as the ethics of diagnosing prodromal movement disorders and the appropriate application of genetic testing in clinical care. Finally, we briefly discuss the current and imagined utility of investigational methods including wearables and genetics in the diagnostic process and, through collaboration, the possibility of a new future in movement disorders and health care.
The clinician–patient relationship remains at the core of medicine and health care. The evolved clinician must aim for the diagnostic prowess of Charcot, the humanistic principles of Osler, and embrace credible new investigational methods to continue to be at the vanguard of clinical care of their patients.[9] [10]
Publication History
Article published online:
17 February 2023
© 2023. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Wijdicks EFM. The first CT scan of the brain: entering the neurologic information age. Neurocrit Care 2018; 28 (03) 273-275
- 2 Grotta JC. Fifty years of acute ischemic stroke treatment: a personal history. Cerebrovasc Dis 2021; 50 (06) 666-680
- 3 Obeso JA, Stamelou M. Past, present, and future of Parkinson's disease: a special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord 2017; 32: 1264-1310
- 4 Lanska DJ. Chapter 33: the history of movement disorders. Handb Clin Neurol 2010; 95: 501-546
- 5 AAMC. The complexities of physician supply and demand: projections from 2017 to 2032 [online]. Accessed November 14, 2022 at: https://www.aamc.org/system/files/c/2/31-2019_update_-_the_complexities_of_physician_supply_and_demand_-_projections_from_2017-2032.pdf
- 6 Dorsey ER, George BP, Leff B, Willis AW. The coming crisis: obtaining care for the growing burden of neurodegenerative conditions. Neurology 2013; 80 (21) 1989-1996
- 7 Sacco RL. Neurology: challenges, opportunities, and the way forward. Neurology 2019; 93 (21) 911-918
- 8 Raggi A, Monasta L, Beghi E. et al. Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019. J Neurol 2022; 269 (04) 2080-2098
- 9 Golden RL. William Osler at 150: an overview of a life. JAMA 1999; 282 (23) 2252-2258
- 10 Goetz CG, Bonduelle M. Charcot as therapeutic interventionist and treating neurologist. Neurology 1995; 45 (11) 2102-2106